MTRR and idiopathic pulmonary fibrosis: This led to increased production of methionine and s-adenosylmethionine, counteracting the fibrotic effect.In conclusion, our findings suggest that chlorquinaldol may serveas a novel antifibrotic medication, with MTRR-mediated methioninemetabolism playing a critical role in IPF development.